NO993653L - FremgangsmÕte for diagnose, prognose og behandling av glaukom og relaterte sykdommer - Google Patents

FremgangsmÕte for diagnose, prognose og behandling av glaukom og relaterte sykdommer

Info

Publication number
NO993653L
NO993653L NO993653A NO993653A NO993653L NO 993653 L NO993653 L NO 993653L NO 993653 A NO993653 A NO 993653A NO 993653 A NO993653 A NO 993653A NO 993653 L NO993653 L NO 993653L
Authority
NO
Norway
Prior art keywords
glaucoma
prognosis
diagnosis
procedure
treatment
Prior art date
Application number
NO993653A
Other languages
English (en)
Other versions
NO993653D0 (no
Inventor
Thai D Nguyen
Jon R Polansky
Pu Chen
Hua Chen
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of NO993653D0 publication Critical patent/NO993653D0/no
Publication of NO993653L publication Critical patent/NO993653L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Eye Examination Apparatus (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
NO993653A 1997-01-28 1999-07-27 FremgangsmÕte for diagnose, prognose og behandling av glaukom og relaterte sykdommer NO993653L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US79115497A 1997-01-28 1997-01-28
US08/938,669 US6171788B1 (en) 1997-01-28 1997-09-26 Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
PCT/US1998/000468 WO1998032850A1 (en) 1997-01-28 1998-01-09 Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders

Publications (2)

Publication Number Publication Date
NO993653D0 NO993653D0 (no) 1999-07-27
NO993653L true NO993653L (no) 1999-09-28

Family

ID=27121110

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993653A NO993653L (no) 1997-01-28 1999-07-27 FremgangsmÕte for diagnose, prognose og behandling av glaukom og relaterte sykdommer

Country Status (10)

Country Link
US (1) US6171788B1 (no)
EP (1) EP1012271B1 (no)
JP (1) JP2001509669A (no)
AT (1) ATE375389T1 (no)
AU (1) AU742405B2 (no)
CA (1) CA2278782C (no)
DE (1) DE69838553T2 (no)
NO (1) NO993653L (no)
NZ (1) NZ336860A (no)
WO (1) WO1998032850A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6956103B2 (en) 1994-04-28 2005-10-18 The University Of Iowa Research Foundation Glaucoma therapeutics and diagnostics
US6403307B1 (en) 1997-03-21 2002-06-11 University Of Iowa Research Foundation Glaucoma therapeutics and diagnostics
US7138511B1 (en) * 1997-01-28 2006-11-21 The Regents Of The University Of California Nucleic acids, kits and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US6171788B1 (en) 1997-01-28 2001-01-09 The Regents Of The University Of California Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US6475724B1 (en) * 1997-01-28 2002-11-05 The Regents Of The University Of California Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
JP2002306165A (ja) * 2000-05-17 2002-10-22 Tsubota:Kk 正常眼圧緑内障を含む開放隅角緑内障の関連遺伝子
US20020168639A1 (en) * 2000-09-22 2002-11-14 Muraca Patrick J. Profile array substrates
US20030119000A1 (en) * 2001-11-05 2003-06-26 Jon Polansky Methods to screen and treat individuals with glaucoma or the propensity to develop glaucoma
US6727354B2 (en) * 2001-12-12 2004-04-27 Quest Diagnostics Investments, Inc. Compositions and methods for TIGR genotyping assays
RU2225982C2 (ru) * 2002-03-11 2004-03-20 Оренбургская государственная медицинская академия Способ прогнозирования репаративной регенерации при заживлении операционной раны вторичным натяжением
RU2227294C2 (ru) * 2002-06-07 2004-04-20 Московский НИИ глазных болезней им. Гельмгольца Способ прогнозирования избыточного рубцевания после антиглаукоматозных операций
US12422441B2 (en) 2018-12-07 2025-09-23 Georgia Tech Research Corporation Antibodies that bind to natively folded myocilin

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3887699A (en) 1969-03-24 1975-06-03 Seymour Yolles Biodegradable polymeric article for dispensing drugs
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
IL63907A0 (en) 1980-09-24 1981-12-31 Cetus Corp Diagnostic method and antibody probe for use therein
PH19942A (en) 1980-11-18 1986-08-14 Sintex Inc Microencapsulation of water soluble polypeptides
IE52535B1 (en) 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
US4582788A (en) 1982-01-22 1986-04-15 Cetus Corporation HLA typing method and cDNA probes used therein
ATE53862T1 (de) 1982-01-22 1990-06-15 Cetus Corp Verfahren zur charakterisierung von hla und die darin benutzten cdns-testmittel.
IL71064A (en) 1983-02-28 1989-10-31 Lifecodes Corp Paternity and forensic test involving analysis of dna polymorphic genetic regions
US4617299A (en) 1983-12-19 1986-10-14 Knepper Paul A Method for the prevention of ocular hypertension, treatment of glaucoma and treatment of ocular hypertension
DE3413608A1 (de) 1984-04-11 1985-10-24 Hoechst Ag, 6230 Frankfurt Implantierbare zubereitungen von regulatorischen peptiden mit gesteuerter freisetzung und verfahren zu ihrer herstellung
US4683194A (en) 1984-05-29 1987-07-28 Cetus Corporation Method for detection of polymorphic restriction sites and nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4757089A (en) 1985-06-14 1988-07-12 Massachusetts Eye And Ear Infirmary Increasing aqueous humor outflow
CA1284931C (en) 1986-03-13 1991-06-18 Henry A. Erlich Process for detecting specific nucleotide variations and genetic polymorphisms present in nucleic acids
GB8606719D0 (en) 1986-03-19 1986-04-23 Lister Preventive Med Genetic probes
DE3612537C1 (de) 1986-04-14 1987-07-16 Dispersa Ag Arzneimittel zur Behandlung von Entzuendungen im Auge
CA1338457C (en) 1986-08-22 1996-07-16 Henry A. Erlich Purified thermostable enzyme
IL86724A (en) 1987-06-19 1995-01-24 Siska Diagnostics Inc Methods and kits for amplification and testing of nucleic acid sequences
ATE92538T1 (de) 1988-01-21 1993-08-15 Genentech Inc Verstaerkung und nachweis von nukleinsaeuresequenzen.
US5192535A (en) 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
IE63392B1 (en) 1988-02-08 1995-04-19 Insite Vision Inc Ophthalmic suspensions
CA1340807C (en) 1988-02-24 1999-11-02 Lawrence T. Malek Nucleic acid amplification process
US5130238A (en) 1988-06-24 1992-07-14 Cangene Corporation Enhanced nucleic acid amplification process
US5190762A (en) 1988-07-06 1993-03-02 Applied Genetics, Inc. Method of administering proteins to living skin cells
ATE138106T1 (de) 1988-07-20 1996-06-15 David Segev Verfahren zur amplifizierung und zum nachweis von nukleinsäuresequenzen
GB2228086A (en) 1988-11-25 1990-08-15 Ici Plc Characterisation of genomic DNA
KR920700360A (ko) 1989-03-22 1992-02-19 하리크 프리드리히 미끄럼 베어링
US5075217A (en) 1989-04-21 1991-12-24 Marshfield Clinic Length polymorphisms in (dC-dA)n ·(dG-dT)n sequences
AU5645690A (en) 1989-05-05 1990-11-29 Lifecodes Corporation Method for genetic analysis of a nucleic acid sample
AU6521790A (en) 1989-10-13 1991-05-16 Hans Schreier Lipophilic acylpyrazinamide prodrugs
US5124154A (en) 1990-06-12 1992-06-23 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5270052A (en) 1991-04-19 1993-12-14 New England Medical Center Hospitals, Inc. Methods and compositions for treatment of infection by intracellular parasites
US5169766A (en) 1991-06-14 1992-12-08 Life Technologies, Inc. Amplification of nucleic acid molecules
WO1993012230A1 (en) 1991-12-13 1993-06-24 Sri International Triple-helix formation at (punpyn).(punpyn) tracts
JPH08502244A (ja) 1992-08-11 1996-03-12 プレジデント アンド フェローズ オブ ハーバード カレッジ 免疫調節ペプチド
US5420120A (en) 1993-12-17 1995-05-30 Alcon Laboratories, Inc. Anti-inflammatory glucocorticoid compounds for topical ophthalmic use
US5474985A (en) 1993-12-22 1995-12-12 The Regents Of The University Of California Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors
US5916778A (en) 1994-04-28 1999-06-29 University Of Iowa Research Foundation Diagnostics based on a glaucoma causing gene
US5885776A (en) 1997-01-30 1999-03-23 University Of Iowa Research Foundation Glaucoma compositions and therapeutic and diagnositic uses therefor
US5925748A (en) 1994-04-28 1999-07-20 The University Of Iowa Research Foundation DNA diagnostics for glaucoma
US5606043A (en) 1994-11-03 1997-02-25 The Regents Of The University Of California Methods for the diagnosis of glaucoma
US5789169A (en) * 1994-11-03 1998-08-04 Regents Of The University Of California Methods for the diagnosis of glaucoma
FR2733251B1 (fr) 1995-04-18 1997-07-04 Inst Nat Sante Rech Med Depistage du glaucome juvenile
US5674888A (en) 1995-06-07 1997-10-07 University Of California Method for the treatment of a trabecular meshwork whose cells are subject to inhibition of cell division
US5599535A (en) 1995-06-07 1997-02-04 Regents Of The University Of California Methods for the cyto-protection of the trabecular meshwork
CA2271235A1 (en) 1996-11-08 1998-05-14 University Of Iowa Research Foundation Glaucoma-associated protein and corresponding nucleic acid and their therapeutic and diagnostic uses
US6171788B1 (en) 1997-01-28 2001-01-09 The Regents Of The University Of California Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
CA2216997A1 (en) 1997-09-30 1999-03-30 Jean Morissette Molecular diagnostic of glaucomas associated with chromosomes 1
AU9334098A (en) 1997-09-30 1999-04-23 Universite Laval Molecular diagnostic of glaucomas associated with chromosomes 1, and method of treatment thereof

Also Published As

Publication number Publication date
ATE375389T1 (de) 2007-10-15
NO993653D0 (no) 1999-07-27
US6171788B1 (en) 2001-01-09
DE69838553T2 (de) 2008-07-03
AU5820498A (en) 1998-08-18
CA2278782C (en) 2004-05-25
AU742405B2 (en) 2002-01-03
JP2001509669A (ja) 2001-07-24
NZ336860A (en) 2001-06-29
EP1012271A1 (en) 2000-06-28
WO1998032850A1 (en) 1998-07-30
CA2278782A1 (en) 1998-07-30
DE69838553D1 (de) 2007-11-22
EP1012271B1 (en) 2007-10-10

Similar Documents

Publication Publication Date Title
DK0996463T3 (da) Katalytiske monoklonale antistoffer med proteaseaktivitet til selektiv lysis af proteinbestanddelen af plaques og aggregater beslægtet med patologiske tilstande
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
NO993653D0 (no) Fremgangsmåte for diagnose, prognose og behandling av glaukom og relaterte sykdommer
DK0910647T3 (da) Human DNase i hyperaktive varianter
DK1053256T3 (da) Antistoffer mod Dødsreceptor 4 (DR4) og anvendelser deraf
DE60220719D1 (de) Antikörper gegen das muc18-antigen
DK0922102T3 (da) Receptor-agonister af hepatocyt-vækstfaktor og anvendelser deraf
BG101024A (bg) Моноклонално антитяло срещу сd44v6
EP1467757A4 (en) USE OF ANTIBODIES TO THE MUC18 ANTIGEN
NO973685L (no) Multi-tumor avvikende vekstgener
DE3781569D1 (de) Mittel zur oralen verwendung.
NO20005990L (no) Platinumkompleks, dets fremstilling og terapeutiske anvendelse
IS2819B (is) Viðloðunarsameindir í æðum og mótun á starfsemi@þeirra
DK0749582T3 (da) Fremgangsmåde til diagnosticering af præeklampsi
ATE318328T1 (de) Diagnostika und therapeutika für osteoporose
BR9509317A (pt) Antagonista a interleucina-1
DE3687097D1 (de) Therapeutisches mittel zur behandlung haematopoietischer krankheiten.
HUP0104408A2 (hu) Mammaglobin, egy szekretált emlőspecifikus mellrák fehérje
DK1196442T3 (da) VGF-polypeptider og fremgangsmåder til behandling af VGF-relaterede lidelser
NO20005919D0 (no) Platinakompleks, dets fremstilling og terapeutisk anvendelse
DK0870036T3 (da) Syntetisk pattedyrs-alfa-N-acetylglucosaminidase og genetiske sekvenser kodende derfor
EP1064402A4 (en) ANTISENSE MODULATION OF LFA-3
DK1196188T3 (da) VGF-selektive monoklonale antistoffer og deres anvendelse til behandling af VGF-relaterede lidelser
DE60005526D1 (de) Verwendung von 2-amino-4-(4-fluoronaphth-1-yl)-6-isopropylpyrimidine zur behandlung von erkrankungen des magen-darm-traktes
DE3777359D1 (de) Aminosaeuresequenz des menschlichen alpha 2-plasmininhibitors und cdns sowie diese aminosaeuresequenz codierende genomische dns.